New Jersey § 26:2j-4

§ 26:2j-4.

a. A health maintenance organization contract for health care services that is delivered,

issued, executed, or renewed in this State pursuant to P.L.1973, c. 337 ( C.26:2J-1 et seq. ), or approved for issuance or renewal in this State by the Commissioner of Banking

and Insurance, on or after the effective date of this act, shall provide health care

services for prescribed, orally administered anticancer medications used to kill or

slow the growth of cancerous cells on a basis no less favorable than the contract

provides for covered intravenously administered or injected anticancer medications. b. Pursuant to subsection a. of this section, coverage for expenses for prescribed,

orally administered anticancer medications used to kill or slow the growth of cancerous

cells shall not be subject to any prior authorization, dollar limit, copayment, deductible

or coinsurance provision that does not apply to intravenously administered or injected

anticancer medications. c. A health maintenance organization contract shall not achieve compliance with the

provisions of this section by imposing an increase in patient cost sharing, including

any copayment, deductible or coinsurance, for anticancer medications, whether intravenously

administered or injected or orally administered, that are covered under the contract

as of the effective date of this act. d. This section shall apply to those contracts for health care services under which

the right to change the schedule of charges for enrollee coverage is reserved.